4//SEC Filing
Zeskind Benjamin J. 4
Accession 0001415889-23-002757
CIK 0001790340other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:16 PM ET
Size
7.7 KB
Accession
0001415889-23-002757
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Award
Stock Option
2023-02-15+352,244→ 352,244 totalExercise: $4.25Exp: 2033-02-15→ Class A Common Stock (352,244 underlying) - Award
Stock Option
2023-02-15+21,756→ 374,000 totalExercise: $4.68Exp: 2028-02-15→ Class A Common Stock (21,756 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027.
- [F2]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001870062
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:16 PM ET
- Size
- 7.7 KB